General Meeting of Shareholders - Софарма Трейдинг АД

General Meeting of Shareholders

The General Meeting consists of all shareholders of Sopharma Trading AD with the right to vote. It is held at least once a year, and its convening is done by invitation, announced in the Commercial Register and the register of non-profit organizations at least 30 days before its opening.

The General Meeting of Shareholders has the exclusive competence to make decisions on the following issues:

  • To amend and supplement the Articles of Association of the company
  • To increase and decrease the capital
  • To transform and terminate the company
  • To elect and dismiss the members of the Board of Directors and determines their remuneration and management guarantee in accordance with the requirements of the law
  • To appoint and dismiss registered auditors
  • To approve the annual financial statement after certification by the appointed registered auditors
  • To decide on the distribution of profits and replenishment of the Reserve Fund, to determine the amount and decide on the payment of a dividend
  • To appoint liquidators upon termination of the company, except in case of bankruptcy
  • To grant a discharge from liability to the members of the Board of Directors
  • To decide on the issuance of bonds
  • To resolve other issues provided in its competence by law or the Articles of Association

Rules for voting by proxy or correspondence

The Articles of Association of Sopharma Trading AD enable the shareholders to vote by proxy or correspondence. The order of voting by proxy or correspondence can be found in the invitation to the relevant General Meeting of Shareholders.

Уважаеми посетители на уебсайта,

Уведомяваме ви, че, считано от 28.04.2021г. новата интернет страница на „Софарма Трейдинг“ АД, от която ще може да получавате актуална информация и материали във връзка с дейността на дружеството, ще бъде с променен домейн адрес, а именно - (вместо досегашния ). В случай че продължите да използвате стария домейн адрес на дружеството, ще се осъществява автоматично препращане към настоящата интернет страница.

Dear website visitors,

We hereby inform you that, as of 28th April, 2021 the new corporate website of Sopharma Trading AD, from which you will be able to receive up-to-date information and materials in connection with the company's activities, will have a changed domain address, namely - (instead of the current ). If you continue to use the company's old domain address, you will be automatically redirected to this website.